Danish drug maker Novo Nordisk is preparing to introduce a new version of its blockbuster drug Ozempic to compete with ...

A citizen-funded quality study of commonly prescribed medicines has found no difference in quality between expensive branded ...

Generic drugmakers target a Rs 5000 crore semaglutide opportunity post-patent expiry, facing regulatory challenges in export ...

India's first private drug quality audit finds generics match branded medicines for safety and efficacy—at a fraction of the ...

The FDA has approved pergolide tablets (Zygolide; Dechra) for controlling clinical signs associated with pituitary pars intermedia dysfunction (PPID) in horses, also known as equine Cushing disease.

China released its fourth catalog of brand-name drugs on Sunday, aiming to foster the development of generic alternatives to ...

Hindustan Laboratories has filed its Draft Red Herring Prospectus (DRHP) with SEBI for an IPO, offering 1.41 million shares.

Generic drug maker Hindustan Laboratories files DRHP with SEBI for IPO comprising fresh issue and OFS; proceeds to fund ...

Hindustan Laboratories, a generic drug maker, files IPO papers with Sebi to raise funds. IPO includes fresh issue and offer ...

In India, the launch of generic semaglutide, expected in the first quarter of FY27, is projected to boost overall Indian Pharmaceutical Market (IPM) growth by 0.5-1%.

As AI continues to mature, Sharma BKP envisions a future where intelligent agents become invisible collaborators, embedded ...

The seats held by Democratic Senators Jon Ossoff in Georgia and Gary Peters in Michigan are viewed as Republicans’ best ...